John K Triantafillidis1,2, Eleni Triantafyllidi2, Michail Sideris3, Theodoros Pittaras4, Apostolos E Papalois2,5. 1. GI Department, Metropolitan General Hospital, 15562 Holargos, Greece. 2. Hellenic Society of Gastrointestinal Oncology, 354, Iera Odos Street, Haidari, 12461 Athens, Greece. 3. Women's Health Research Unit, Queen Mary University of London, London E1 2AB, UK. 4. Hematology Laboratory-Blood Bank, Aretaieion Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece. 5. Special Unit for Biomedical Research and Education, School of Medicine, Aristotle University of Thessaloniki, 60 El. Venizelou Street, Aghia Paraskevi, 15341 Athens, Greece.
Abstract
BACKGROUND: Pancreatic cancer represents the most lethal malignancy among all digestive cancers. Despite the therapeutic advances achieved during recent years, the prognosis of this neoplasm remains disappointing. An enormous amount of experimental (mainly) and clinical research has recently emerged referring to the effectiveness of various plants administered either alone or in combination with chemotherapeutic agents. Apart from Asian countries, the use of these plants and herbals in the treatment of digestive cancer is also increasing in a number of Western countries as well. The aim of this study is to review the available literature regarding the efficacy of plants and herbals in pancreatic cancer. METHODS: The authors have reviewed all the experimental and clinical studies published in Medline and Embase, up to June 2021. RESULTS: More than 100 plants and herbals were thoroughly investigated. Favorable effects concerning the inhibition of cancer cell lines in the experimental studies and a favorable clinical outcome after combining various plants with established chemotherapeutic agents were observed. These herbals and plants exerted their activity against pancreatic cancer via a number of mechanisms. The number and severity of side-effects are generally of a mild degree. CONCLUSION: A quite high number of clinical and experimental studies confirmed the beneficial effect of many plants and herbals in pancreatic cancer. More large, double-blind clinical studies assessing these natural products, either alone or in combination with chemotherapeutic agents should be conducted.
BACKGROUND: Pancreatic cancer represents the most lethal malignancy among all digestive cancers. Despite the therapeutic advances achieved during recent years, the prognosis of this neoplasm remains disappointing. An enormous amount of experimental (mainly) and clinical research has recently emerged referring to the effectiveness of various plants administered either alone or in combination with chemotherapeutic agents. Apart from Asian countries, the use of these plants and herbals in the treatment of digestive cancer is also increasing in a number of Western countries as well. The aim of this study is to review the available literature regarding the efficacy of plants and herbals in pancreatic cancer. METHODS: The authors have reviewed all the experimental and clinical studies published in Medline and Embase, up to June 2021. RESULTS: More than 100 plants and herbals were thoroughly investigated. Favorable effects concerning the inhibition of cancer cell lines in the experimental studies and a favorable clinical outcome after combining various plants with established chemotherapeutic agents were observed. These herbals and plants exerted their activity against pancreatic cancer via a number of mechanisms. The number and severity of side-effects are generally of a mild degree. CONCLUSION: A quite high number of clinical and experimental studies confirmed the beneficial effect of many plants and herbals in pancreatic cancer. More large, double-blind clinical studies assessing these natural products, either alone or in combination with chemotherapeutic agents should be conducted.
Entities:
Keywords:
alternative medicine; alternative treatment; chinese medicine; herbals; medical plants; pancreatic cancer
Authors: María P Torres; Satyanarayana Rachagani; Vinee Purohit; Poomy Pandey; Suhasini Joshi; Erik D Moore; Sonny L Johansson; Pankaj K Singh; Apar K Ganti; Surinder K Batra Journal: Cancer Lett Date: 2012-04-01 Impact factor: 8.679
Authors: Michel Ducreux; Thomas Seufferlein; Jean-Luc Van Laethem; Pierre Laurent-Puig; Cristina Smolenschi; David Malka; Valérie Boige; Antoine Hollebecque; Thierry Conroy Journal: Semin Oncol Date: 2018-12-27 Impact factor: 4.929
Authors: Jingjing Gong; Amanda R Muñoz; Subramanya Pingali; Florastina Payton-Stewart; Daniel E Chan; James W Freeman; Rita Ghosh; Addanki P Kumar Journal: Mol Carcinog Date: 2016-05-25 Impact factor: 4.784